TG Therapeutics Inc (NASDAQ:TGTX)

5.35
Delayed Data
As of Oct 15
 0.00 / 0.00%
Today’s Change
3.32
Today|||52-Week Range
9.38
+30.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues152.4K152.4K152.4K152.0K
 
 
 
 
 
Depreciation And Amortization15.5K63.0K82.4K88.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses63.3M79.1M118.8M174.5M
 
 
 
 
 
Research And Development47.7M69.2M102.5M159.4M
 
 
 
 
 
Total Operating Expenses63.3M79.1M118.9M174.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-63.2M-79.0M-118.7M-174.4M
 
 
 
 
 
Extraordinary Credit1.0M995.7K786.1K939.0K
 
 
 
 
 
Interest Expense On Debt972.7K886.1K0.00--
 
 
 
Other Expenses0.00283.5K-844.8K-878.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-62.9M-78.3M-118.5M-173.5M
 
 
 
 
 
Net Income-62.9M-78.3M-118.5M-173.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS45.6M49.0M62.1M75.5M
 
 
 
 
 
Shares To Calculate EPS Diluted45.6M49.0M62.1M75.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.38-$1.60-$1.91-$2.30
 
 
 
 
 
EPS Diluted-$1.38-$1.60-$1.91-$2.30